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Background: We compared the incidence and degree of post-operative nausea and vomiting (PONV) in patients who 
received general anesthesia with propofol or sevoflurane using the Rhodes index of nausea, vomiting, and retching 
(RINVR) to assess the degree of PONV quantitatively and objectively during the post-anesthetic period. 
Methods: We performed a prospective study involving 38 patients who underwent gynecologic laparoscopic surgery 
in our hospital between September 2008 and August 2009. Nineteen patients were anesthetized with propofol during 
the entire anesthetic period and the other 19 patients received 2.0 mg/kg of propofol intravenously, followed by 
sevoflurane inhalation. Three patients who were anesthetized with sevoflurane were excluded from the analysis 
because they were omitted during the survey. We studied the patients who had PONV and RINVR scores 1, 6, and 24 
hours post-operatively. 
Results: The propofol group had a statistically lower incidence of PONV and lower RINVR scores in the following 
subclasses within 1 hour of surgery: symptom occurrence; symptom distress; and symptom experience. 
Conclusions: Propofol at induction and during maintenance of anesthesia can be used to prevent PONV within 1 
hour post-operatively in patients undergoing gynecologic laparoscopic surgery. (Korean J Anesthesiol 2011; 60: 36-40)
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Introduction
    The incidence of post-operative nausea and vomiting (PONV) 
in patients who undergo operations in which general anesthesia 
is administered has been reported to range 20-30% [1]. PONV 
results in some of the most severe discomfort amongst patients, 
along with post-operative pain. The causes of PONV are many 
and varied based on patient, and surgery-, and anesthesia-
related factors, and PONV occurs frequently in patients 
undergoing gynecologic laparoscopic surgery [1]. With respect 
to anesthetic agents, nitrous oxide and volatile anesthetics 
increase the occurrence of PONV, but propofol is known to have 
an anti-emetic effect [1,2].
    The Rhodes index of nausea, vomiting, and retching (RINVR) 
is a method of quantifying nausea and vomiting objectively 
in patients who receive anti-cancer therapy. Compared with 
the method of simply detecting PONV occurrence or with the 
method of measuring the degree of PONV subjectively using a 
visual analogue scale (VAS), RINVR is a more suitable method 
for quantitatively and objectively assessing the degree of PONV 
that patients may feel [3]. 
    However, research which has compared the degree of PONV 
after general anesthesia with propofol or sevoflurane at each set 
time during the post-anesthetic period using RINVR is limited.
    Thus, the purpose of this study was to compare the number of 
patients who have symptoms of PONV and the objective degree 
of PONV which occurs after general anesthesia with propofol or 
sevoflurane at each set time during the post-anesthetic period 
in patients with multiple risk factors for PONV, such as female 
gender, gynecologic laparoscopic surgery, and post-operative 
opioid therapy. 
Materials and Methods
    After obtaining approval of the Institutional Review Board of our 
hospital, female patients who were admitted to the Department 
of Obstetrics and Gynecology between September 2008 and 
August 2009 and underwent laparoscopic total hysterectomy and 
laparoscopy-assisted vaginal hysterectomy were included in this 
study. The subjects of our study were patients who were between 
19 and 69 years of age and classified as American Society of 
Anesthesiologists physical status I or II. Patients who had a 
history of PONV or motion sickness were excluded. At the pre-
operative visit, anesthesiologists obtained written informed 
consent from each patient after explaining the methods and the 
purpose of this study, but did not administer pre-medication. 
We classified patients who were anesthetized with propofol 
as group P and the other patients who were anesthetized with 
sevoflurane as group S. The patients were alternately assigned 
to the groups according to the order in which they came to the 
hospital. Thirty-eight patients were included in this study; 19 
patients were assigned to groups P and S. Three patients who 
were anesthetized with sevoflurane were excluded from the 
analysis because they were omitted during the survey. 
    The age, height, weight, BMI, pre-operative hemoglobin 
level, total amount of fluid administered during surgery, total 
anesthesia and operative times, and visual analogue scale (VAS) 
scores of the patients in both groups at each set time during the 
post-anesthetic period are shown in Table 1. 
    In the group P patients, 4.0-5.0 μg/ml of propofol and 1.5 ng/
ml of remifentanil were injected intravenously using a target-
controlled infusion (TCI) to induce general anesthesia. After 
confirming loss of consciousness, we injected 0.6 mg/kg of 
rocuronium intravenously and intubated the patient 3 minutes 
after injection. The anesthesia was maintained with propofol 
and remifentanil and the concentration of TCI was controlled 
to keep the blood pressure within a 20% range of the baseline 
blood pressure. In group S patients, 2.0 mg/kg of propofol 
was injected intravenously and 1.5 ng/ml of remifentanil was 
infused continuously using TCI to induce general anesthesia. 
After confirming loss of consciousness, sevoflurane (3 vol%) was 
administered via facial mask. Then, we injected 0.6 mg/kg of 
rocuronium intravenously and intubated the patient 3 minutes 
thereafter. The anesthesia was maintained with continuous 
infusion of remifentanil by TCI and sevoflurane inhalation, 
and the concentration of anesthetic agents was controlled to 
maintain the blood pressure within a 20% range of the baseline 
blood pressure. All patients were intubated without difficulty 
and maintained at a FiO2 of 0.5 using air-oxygen. The patients 
in both groups were injected with 1 μg/kg of fentanyl and 30 
mg of ketorolac intravenously for post-operative pain control 
30 minutes before the surgical procedure was completed. Then, 
intravenous, patient-controlled analgesia (24 μg/kg of fentanyl 
and 8 mg of ondansetron) was initiated. 
Table 1.  Patient Characteristics, Procedure Factors, and Visual 
Analogue Scale after Surgery 
Group P (n = 19) Group S (n = 16)
Age (yr)
Height (cm)
Weight (kg)
BMI
Pre-operative Hb (g/dl)
Total fluids during surgery (ml)
Total anesthesia times (min)
Total operation times (min)
VAS, 1 hour after surgery
VAS, 6 hours after surgery
VAS, 24 hours after surgery
38.6 ± 11.7
156.5 ± 5.3
58.0 ± 7.2
23.7  ± 3.1
12.3  ± 1.5
976  ± 446
154  ± 50
121  ± 49
4.5  ± 1.9
2.5  ± 1.8
1.7  ± 1.2
41.9  ± 8.9
159.0 ± 5.0
60.0 ± 8.7
23.7  ± 3.0
12.3  ± 1.2
872 ± 350
145 ± 50
118  ± 55
4.63  ± 1.9
2.3  ± 2.3
1.1  ± 1.0
Values are the mean ± SD.  Group P is the propofol group. Group S is 
the sevoflurane group. There were no significant difference between 
the two groups. 38 www.ekja.org
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    PONV assessment was made by an anesthesiologist using 
the questionnaire at 1, 6, and 24 hours post-operatively using 
the RINVR (Table 2). The RINVR consisted of 8 questions; each 
question had 5 examples, and the patients were asked to mark 
the example that applied to them personally. We scored each 
example of every question on a scale of 0 (the symptom was 
none or mild) to 4 (the symptom was a lot or severe). After 
the questionnaire was completed, the scores of examples that 
each patient marked were summed and categorized as follows: 
subclass of symptom occurrence (SOSO; question numbers 1, 
4, 6, 7, and 8), which focused on the occurrence of symptoms; 
subclass of symptom distress (SOSD; question numbers 2, 
3, and 5), which focused on the distress of symptoms; and 
subclass of symptom experience (SOSE; all 8 questions). The 
calculated scores of the two groups were compared according 
to each subclass at each set time during the post-anesthetic 
period. Also, when the RINVR score was ≥1, we presumed 
that PONV occurred. The number of patients who had PONV 
during the 24 hours after the surgical procedure and at each set 
time during the post-anesthetic period was calculated and the 
number of the patients in the two groups was compared to each 
other. Even if 1 person experienced PONV several times during 
the 24-hour post-operative period, we considered it as one 
person. 
    Assuming the incidence of PONV within 24 hours following 
gynecologic surgery using volatile anesthetics to be 45% and the 
40% difference in the incidence of PONV between the 2 groups 
as clinically significant, we calculated the number of patients in 
the current study based on an existing study [4]. As we defined 
the incidence of PONV within 24 hours after surgery to be the 
primary outcome of this study, we calculated that 16 patients 
would be required in each group to achieve an 80% statistical 
power at a 5% significance level to detect a true difference 
between the 2 groups. Assuming the possibility of being 
dropped out during the study, we decided to choose 19 patients 
per group. 
    The statistical analysis was done using SPSS (version 12.0; 
SPSS, Inc., Chicago, IL, USA). Age, height, weight, BMI, pre-
operative hemoglobin level, total amount of fluids administered 
during surgery, total anesthesia time, and VAS score of each 
set time during the post-anesthetic period in both groups were 
analyzed using an unpaired t-test. The RINVR scores of each 
set time during the post-anesthetic period were analyzed by 
the Mann-Whitney U test. The number of patients who had 
symptoms of PONV at each set time during the post-anesthetic 
period and the total number of patients during 24 hours after 
surgery were analyzed by Fisher’s exact test. A statistically 
significant difference was assumed for a P < 0.05. 
Results
    The RINVR scores for SOSO, SOSD, and SOSE 1 hour post-
operatively were significantly lower in group P than group S, but 
there was no difference at 6 and 24 hours postoperatively (Table 3). 
    The incidence of PONV during the 24 hours post-operatively 
was 15.8% (3 patients) in group P and 75.0% (12 patients) in 
group S; thus, the incidence of PONV in group P during the 
first 24 hours post-operatively was significantly lower than 
group S. In each set time during the post-anesthetic period, 
the number of patients with symptoms of PONV within 1 
hour post-operatively in group P was 5.3% (1 patient) and 
62.5% (10 patients) in group S; thus, the number of patients 
with symptoms of PONV within 1 hour post-operatively in 
group P was significantly lower than group S, but there was no 
Table 2.  A Questionnaire for the Rhodes Index of Nausea, Vomiting, and Retching (RINVR) at N Hours after Surgery
Scores 4 3 2 1 0
1. In the last N hours, I threw up __ times.
2. In the last N hours, from retching and dry heaves, 
       I felt __ distress.
3. In the last N hours, from vomiting or throwing up, 
       I have felt __ distress.
4. In the last N hours, I have felt nauseated or 
       sick to my stomach __.
5. In the last N hours, because of nausea/sickness, 
       I have felt __ distress.
6. In the last N hours, each time I threw up, 
       I produced a __ amount.
7. In the last N hours, I have felt nauseated or sick 
       to my stomach __ times.
8. In the last N hours, I have had periods of retching 
       or dry heaves without bringing anything up __ times.
7 or more
Severe
Severe
More than 4 
hours
Severe
Very large
(3 cups or more)
7 or more
7 or more
5-6
Great
Great
2-3 hours
Great
Large
(2-3 cups)
5-6
5-6
3-4
Moderate
Moderate
1-2 hours
Moderate
Moderate 
(1/2-2 cups)
3-4
3-4
1-2
Mild
Mild
1 hour less
Mild
Small
(up to 1/2 cup)
1-2
1-2
I did not  
throw up
No
No
Not at all
No
I did not 
throw up
No
No
N is 1, 6, and 24 h in this study. 39 www.ekja.org
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difference between 1 and 6 hours, and 6 and 24 hours after post-
operatively (Table 4). 
Discussion
    In addition to post-operative pain, PONV is among the most 
severe discomfort experienced by patients post-operatively. 
Apfel et al. [5] considered female gender, non-smokers, a history 
of PONV and motion sickness, and post-operative opioid 
therapy as important independent causal factors for PONV. 
Laparoscopic surgery is also known to increase the incidence of 
PONV [1]. The patients included in the current study had at least 
3 risk factors for PONV, including female gender, laparoscopic 
surgery, and post-operative opioid therapy. 
    In the current study, we used RINVR scores to assess PONV. 
The RINVR score has been suggested to assess the degree of 
nausea and vomiting objectively in patients under treatment for 
cancer [6,7]. Kim et al. [3] reported that assessing PONV with 
RINVR objectively and quantitatively is a reliable index. 
    The incidence of PONV during the first 24 hours post-
operatively in the case of propofol was significantly lower than 
sevoflurane (Table 4), and corresponds to the existing results 
that have been established for the anti-emetic effect of propofol 
[8]. 
    While the number of patients with PONV within 1 hour post-
operatively in the case of propofol was significantly less than 
sevoflurane, there were no differences in the number of patients 
with symptoms of PONV from 1-6 hours and 6-24 hours post-
operatively. The results of assessing PONV with RINVR scores 
in the case of propofol were significantly lower than sevoflurane 
at 1 hour post-operatively only and there were no differences 
in RINVR scores at 6 and 24 hours post-operatively between 
the 2 groups. Apfel et al. [9] reported that volatile anesthetics 
were the main cause of nausea and vomiting within 2 hours 
post-operatively. Because of the short duration of action, it 
is known that propofol does not show enough anti-emetic 
effect for PONV, which occurs after the patient is transferred 
to the general ward [10]. Because the patients in group P were 
anesthetized with propofol, which has an anti-emetic effect, 
and in group S with volatile anesthetics, which causes early 
PONV, it seems that the RINVR score 1 hour post-operatively 
in patients administered propofol was significantly lower than 
that in patients administered sevoflurane; however, there was 
no difference in the RINVR scores between the 2 groups after 1 
hour because the effect of volatile anesthetics in patients with 
sevoflurane decreased after 1 hour. 
    In the current study, the number of patients who had newly 
developed PONV 1 hour post-operatively was 2 each for propofol 
and sevoflurane. Because the context-sensitive half-time of 
propofol and remifentanil is 30 and 3 minutes, respectively [11], 
when the average anesthesia time is 3 hours, we reasoned that 
the new onset PONV in 2 patients who received propofol 1-6 
hours post-operatively was due to factors other than anesthesia, 
such as gynecologic surgery, laparoscopic surgery, or pain 
[1,12]. Similarly, we suggest that the majority of patients who 
had received with sevoflurane had PONV within 1 hour post-
operatively because of residual volatile anesthetics. Because 
the time required to reduce the partial pressure of sevoflurane 
in the alveola to 90% is <30 minutes [13] when the average 
anesthesia time is 3 hours, we reasoned that the 2 patients 
with new onset PONV 1-6 hours post-operatively in the case 
of sevoflurane also had PONV not because of the effect of the 
residual volatile anesthetics, but because of factors other than 
anesthesia. There were no patients with new onset PONV 6 
hours post-operatively in the 2 groups because factors other 
than anesthesia lost effect as time went by. 
    Thirty minutes before the end of the surgical procedure, all of 
Table 3.  Scores of Rhodes Index of Nausea, Vomiting, and Retching 
(RINVR) 
Subclass of 
RINVR
Group P 
(n = 19)
Mean
Group S 
(n = 16)
Mean
Within 1 h after surgery
Between 1 and 6 h
  after surgery
Between 6 and 24 h 
  after surgery
SOSO
SOSD
SOSE
SOSO
SOSD
SOSE
SOSO
SOSD
SOSE
 0.0 ± 0.0*
 0.1 ± 0.2*
 0.1 ± 0.2*
0.3 ± 0.9
0.2 ± 0.7
0.4 ± 1.6
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
1.8 ± 2.4
2.3 ± 2.6
4.1 ± 4.8
0.8 ± 1.5
0.9 ± 1.9
1.7 ± 3.4
0.0 ± 0.0
0.0 ± 0.0
0.0 ± 0.0
Values are the mean ± SD.  Group P is the propofol group.  Group S 
is the sevoflurane group.  SOSO:  subclass of symptom occurrence.   
SOSD:  subclass of symptom distress.  SOSE:  subclass of symptom 
experience.  *Significantly different from group S, P < 0.05.
Table 4.  The Number of Patients with Symptoms of PONV at Each 
Set Time during the Post-anesthetic Period 
Group P (n = 19) Group S (n = 16)
PONV (+) PONV (+)
Within 1 h after surgery
Between 1 and 6 h after surgery
Between 6 and 24 h after surgery 
Within 24 h after surgery
 1 (1)*
2 (2)
0 (0)
 3 (3)*
10 (10)
5 (2)
0 (0)
12 (12)
Values before the parentheses are the numbers of patients with 
symptoms of PONV at each set time during the post-anesthetic 
period.  Values in parentheses are the numbers of patients with 
newly developed symptoms of PONV at each set time during the 
post-anesthetic period.  PONV:  post-operative nausea and vomiting.   
Group P is the propofol group.  Group S is the sevoflurane group.   
*Significantly different from group S and P < 0.05. 40 www.ekja.org
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the patients were injected with 1 μg/kg of fentanyl intravenously 
for post-operative pain control, and intravenous patient-
controlled analgesia, which was mixed with 24 μg/kg of fentanyl 
and 8 mg of ondansetron. According to Ding and White’s study 
[14], the analgesic dose of fentanyl used during the surgical 
procedure does not increase PONV and an ondansetron 
infusion using intravenous patient-controlled analgesia is 
known to be effective in preventing PONV.
    At 1 hour post-operatively, most of the patients are in the 
post-anesthetic care unit or on general ward immediately after 
being transferred. During this period, the incidence of PONV 
owing to the effect of residual volatile anesthetics is high. 
Therefore, a lower RINVR score in the case of using propofol 
than sevoflurane within 1 hour following surgery is clinically 
important. 
    In conclusion, total intravenous anesthesia with propofol 
in gynecologic laparoscopic surgery is more effective than 
inhalation anesthesia using sevoflurane for decreasing PONV 
within 1 hour post-operatively. 
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